Literature DB >> 21642472

Role of von Hippel-Lindau protein in fibroblast proliferation and fibrosis.

Qiyuan Zhou1, Annie Pardo, Melanie Königshoff, Oliver Eickelberg, G R Scott Budinger, Krishna Thavarajah, Cara J Gottardi, Jonathan Jones, John Varga, Moises Selman, Jacob I Sznajder, J Usha Raj, Guofei Zhou.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is characterized by exaggerated fibroblast proliferation and accumulation of collagens and fibronectin. The extracellular fibronectin and collagen network is regulated by von Hippel-Lindau protein (pVHL). However, it is unknown whether pVHL contributes to pulmonary fibrosis. We found that lungs from patients with IPF expressed increased levels of pVHL in fibroblastic foci. Bleomycin treatment also induced pVHL in lung fibroblasts, but not in alveolar type II cells. Overexpression of pVHL increased lung fibroblast proliferation, protein abundance of fibronectin and collagen, and extracellular fibronectin. In addition, overexpression of pVHL induced expression of the α5 integrin subunit. Overexpression of pVHL did not alter hypoxia-inducible factor luciferase reporter activity and mRNA expression of vascular endothelial growth factor. Fibroblasts overexpressing pVHL were more sensitive to RGD peptide-mediated reduction in proliferation. Activating α5 and β1 integrin increased proliferation of fibroblasts overexpressing pVHL and those cells were more resistant to the inhibition of α5 integrin. Overexpression of pVHL also increased activation of focal adhesion kinase (FAK). Moreover, suppression of pVHL prevented TGF-β1-induced proliferation of mouse embryonic fibroblasts. Taken together, our results indicate that elevated expression of pVHL results in the aberrant fibronectin expression, activation of integrin/FAK signaling, fibroblast proliferation, and fibrosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21642472      PMCID: PMC3157679          DOI: 10.1096/fj.10-177824

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  40 in total

1.  Changes in integrin expression during adipocyte differentiation.

Authors:  Jun Liu; Stephanie M DeYoung; Ming Zhang; Mei Zhang; Alan Cheng; Alan R Saltiel
Journal:  Cell Metab       Date:  2005-09       Impact factor: 27.287

2.  Characterization of a von Hippel Lindau pathway involved in extracellular matrix remodeling, cell invasion, and angiogenesis.

Authors:  Ghada Kurban; Valérie Hudon; Eric Duplan; Michael Ohh; Arnim Pause
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

3.  Fibronectin regulates latent transforming growth factor-beta (TGF beta) by controlling matrix assembly of latent TGF beta-binding protein-1.

Authors:  Sarah L Dallas; Pitchumani Sivakumar; Carolyn J P Jones; Qian Chen; Donna M Peters; Deane F Mosher; Martin J Humphries; Cay M Kielty
Journal:  J Biol Chem       Date:  2005-01-27       Impact factor: 5.157

4.  Fibronectin is required for integrin alphavbeta6-mediated activation of latent TGF-beta complexes containing LTBP-1.

Authors:  Laura Fontana; Yan Chen; Petra Prijatelj; Takao Sakai; Reinhard Fässler; Lynn Y Sakai; Daniel B Rifkin
Journal:  FASEB J       Date:  2005-11       Impact factor: 5.191

5.  Decreased growth of Vhl-/- fibrosarcomas is associated with elevated levels of cyclin kinase inhibitors p21 and p27.

Authors:  Fiona A Mack; Jagruti H Patel; Mangatt P Biju; Volker H Haase; M Celeste Simon
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

6.  The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis.

Authors:  J S Munger; X Huang; H Kawakatsu; M J Griffiths; S L Dalton; J Wu; J F Pittet; N Kaminski; C Garat; M A Matthay; D B Rifkin; D Sheppard
Journal:  Cell       Date:  1999-02-05       Impact factor: 41.582

7.  Proapoptotic Bid is required for pulmonary fibrosis.

Authors:  G R Scott Budinger; Gökhan M Mutlu; James Eisenbart; Alyson C Fuller; Amy A Bellmeyer; Christina M Baker; Mindy Wilson; Karen Ridge; Terrence A Barrett; Vivian Y Lee; Navdeep S Chandel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-14       Impact factor: 11.205

8.  pVHL function is essential for endothelial extracellular matrix deposition.

Authors:  Nan Tang; Fiona Mack; Volker H Haase; M Celeste Simon; Randall S Johnson
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

9.  The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix.

Authors:  M Ohh; R L Yauch; K M Lonergan; J M Whaley; A O Stemmer-Rachamimov; D N Louis; B J Gavin; N Kley; W G Kaelin; O Iliopoulos
Journal:  Mol Cell       Date:  1998-06       Impact factor: 17.970

10.  Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis.

Authors:  Annie Pardo; Kevin Gibson; José Cisneros; Thomas J Richards; Yinke Yang; Carina Becerril; Samueal Yousem; Iliana Herrera; Victor Ruiz; Moisés Selman; Naftali Kaminski
Journal:  PLoS Med       Date:  2005-09-06       Impact factor: 11.069

View more
  13 in total

Review 1.  The extracellular matrix and ciliary signaling.

Authors:  Tamina Seeger-Nukpezah; Erica A Golemis
Journal:  Curr Opin Cell Biol       Date:  2012-07-19       Impact factor: 8.382

2.  Suppression of von Hippel-Lindau Protein in Fibroblasts Protects against Bleomycin-Induced Pulmonary Fibrosis.

Authors:  Qiyuan Zhou; Tianji Chen; Wei Zhang; Melike Bozkanat; Yongchao Li; Lei Xiao; Richard B van Breemen; John W Christman; Jacob I Sznajder; Guofei Zhou
Journal:  Am J Respir Cell Mol Biol       Date:  2016-05       Impact factor: 6.914

3.  Smooth muscle cell-specific FoxM1 controls hypoxia-induced pulmonary hypertension.

Authors:  Jingbo Dai; Qiyuan Zhou; Haiyang Tang; Tianji Chen; Jing Li; Pradip Raychaudhuri; Jason X-J Yuan; Guofei Zhou
Journal:  Cell Signal       Date:  2018-08-06       Impact factor: 4.315

4.  Protein Expression by Human Pulmonary Artery Smooth Muscle Cells Containing a BMPR2 Mutation and the Action of ET-1 as Determined by Proteomic Mass Spectrometry.

Authors:  Chunxiang Yao; Jun Yu; Linda Taylor; Peter Polgar; Mark E McComb; Catherine E Costello
Journal:  Int J Mass Spectrom       Date:  2015-02-15       Impact factor: 1.986

5.  Downregulation of PKCζ/Pard3/Pard6b is responsible for lung adenocarcinoma cell EMT and invasion.

Authors:  Qiyuan Zhou; Jingbo Dai; Tianji Chen; Laura A Dada; Xu Zhang; Wei Zhang; Malcolm M DeCamp; Robert A Winn; Jacob I Sznajder; Guofei Zhou
Journal:  Cell Signal       Date:  2017-06-24       Impact factor: 4.315

6.  Knockdown of von Hippel-Lindau protein decreases lung cancer cell proliferation and colonization.

Authors:  Qiyuan Zhou; Tianji Chen; Joyce Christina F Ibe; J Usha Raj; Guofei Zhou
Journal:  FEBS Lett       Date:  2012-04-20       Impact factor: 4.124

7.  Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2.

Authors:  Vera Ivanova; Olga B Garbuzenko; Kenneth R Reuhl; David C Reimer; Vitaly P Pozharov; Tamara Minko
Journal:  Eur J Pharm Biopharm       Date:  2012-12-08       Impact factor: 5.571

8.  Angiotensinogen gene transcription in pulmonary fibrosis.

Authors:  Bruce D Uhal; My-Trang T Dang; Xiaopeng Li; Amal Abdul-Hafez
Journal:  Int J Pept       Date:  2012-02-20

9.  Intratracheal instillation of high dose adenoviral vectors is sufficient to induce lung injury and fibrosis in mice.

Authors:  Qiyuan Zhou; Tianji Chen; Melike Bozkanat; Joyce Christina F Ibe; John W Christman; J Usha Raj; Guofei Zhou
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

10.  Gene expression in uterine leiomyoma from tumors likely to be growing (from black women over 35) and tumors likely to be non-growing (from white women over 35).

Authors:  Barbara J Davis; John I Risinger; Gadisetti V R Chandramouli; Pierre R Bushel; Donna Day Baird; Shyamal D Peddada
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.